Raltitrexed is an antimetabolite chemotherapy medication belonging to the folate analogue class, used primarily to treat advanced colorectal cancer and locally advanced rectal cancer by inhibiting thymidylate… Read more
Raltitrexed is an antimetabolite chemotherapy medication belonging to the folate analogue class, used primarily to treat advanced colorectal cancer and locally advanced rectal cancer by inhibiting thymidylate synthase to block DNA synthesis. The Raltitrexed category provides essential analytical tools for pharmaceutical development and quality control, including high-purity reference standards of the API, pharmacopeial and non-pharmacopeial impurities, and relevant metabolites. These compounds are critical for accurate impurity profiling and method validation, ensuring compliance with strict regulatory standards. Laboratories also utilize stable isotope labelled Raltitrexed compounds as internal standards in mass spectrometry-based assays, facilitating precise quantification and pharmacokinetic studies. By providing access to these key reference materials, researchers can reliably monitor drug stability and investigate potential degradation pathways in both development and manufacturing environments.